Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team

DURHAM, N.C., March 31 /PRNewswire/ -- Pharmaceutical Strategic
Initiatives (PSI), a provider of marketing consultation and content
development services to the pharmaceutical industry, has added Anne L. Sexton
MD, MS to its management team as Vice President of Medical Activities.
Dr. Sexton brings 15 years of clinical and pharmaceutical experience to
PSI. Dr. Sexton's broad experience includes medical affairs and medical
monitoring, drug development strategy, regulatory affairs activities
including FDA submissions, drug safety/pharmacovigilance and medical writing.
According to PSI President Charles Carter, PhD, "Anne brings the clinical
and industry experience our customers need to develop and implement their
integrated medical affairs strategies and support regulatory initiatives."
Prior to joining PSI, Dr. Sexton headed an independent consulting company
serving the pharmaceutical and biotech industries.
About Pharmaceutical Strategic Initiatives
PSI was founded in 1988 by Charles Carter, PharmD, MBA and is part of
Interactive Holdings. PSI provides strategic marketing consultation and
content development services to the pharmaceutical industry. For more
information about PSI, contact Mary Messina at 919.314.1380 or visit
www.psillc.com.
SOURCE Pharmaceutical Strategic Initiatives

Mary Messina of Pharmaceutical Strategic Initiatives, +1-919-314-1380